Oct 13 (Reuters) - Trillium Therapeutics Inc TRIL.TO :
* TRILLIUM THERAPEUTICS - ON OCT 12, 2021, PFIZER VOLUNTARILY WITHDREW ITS HART-SCOTT-RODINO ACT FILING, AND EXPECTS TO RE-FILE SUCH FORM ON OR ABOUT OCTOBER 14
* TRILLIUM THERAPEUTICS INC - CO, PFIZER ARE WORKING COOPERATIVELY WITH APPLICABLE REGULATORY AUTHORITIES IN THEIR REVIEW OF PROPOSED ARRANGEMENT
* TRILLIUM THERAPEUTICS INC - CO, PFIZER CONTINUE TO EXPECT TO CONSUMMATE ARRANGEMENT IN Q4 OF 2021 OR FIRST HALF OF 2022
Further company coverage: TRIL.TO